title: Safety of leukoreduced, cytomegalovirus (CMV)-untested components in CMV-negative allogeneic human progenitor cell transplant recipients.
authors.forename: Tammon
authors.initials: T
authors.lastname: Nash
authors.forename: Sandra
authors.initials: S
authors.lastname: Hoffmann
authors.forename: Suzanne
authors.initials: S
authors.lastname: Butch
authors.forename: Robertson
authors.initials: R
authors.lastname: Davenport
authors.forename: Laura
authors.initials: L
authors.lastname: Cooling
mesh_terms: D000328:Adult; D000914:Antibodies, Viral / Q000096:biosynthesis / Q000097:blood; D002648:Child; D003587:Cytomegalovirus / Q000276:immunology; D003586:Cytomegalovirus Infections / Q000175:diagnosis / Q000453:epidemiology / Q000517:prevention & control* / Q000635:transmission; D005260:Female; D005500:Follow-Up Studies; D019337:Hematologic Neoplasms / Q000150:complications / Q000601:surgery; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects / Q000592:standards; D006412:Hematopoietic Stem Cells / Q000821:virology; D006801:Humans; D047589:Leukocyte Reduction Procedures; D007962:Leukocytes / Q000821:virology; D008297:Male; D021141:Nucleic Acid Amplification Techniques; D012189:Retrospective Studies; D065227:Transfusion Reaction; D014184:Transplantation, Homologous; D019564:Unnecessary Procedures
chemical_list: D000914:Antibodies, Viral